spine-addiction-2018-keynote

9 / 11

Page 40
Notes:
Journal of Neurology and Neurorehabilitation Research | Volume 3
allied
academies
November 26-27, 2018 | Dubai, UAE
Spine and Spine Disorders
Addiction Research and Therapy
3rd International Conference on
International Conference on
Joint Event
&
Objective: I here report the contribution of Discal Treatment by
Disc -FXTM in a pathway of interventional management of back
pain and sciatica in daily clinical practice.
Design: Prospective, Sequential, Open label case series as
observed in clinical practice.
Setting: Single practitioner, Private practice, Southeast England
Patients: 100 sequential cases. 53 women. Mean age 44.8yrs.
38 back pain, 40 back and leg, 5 Sciatica, 10complex (7 non-
assigned). Mean total duration of pain 58.5 months, continuous
pain 22.4 months. 1, 2, 3 and 4 levels treated in 39, 52, 8 and
1 cases respectively. Follow-up was until clinical discharge.
Minimum 1month, maximum 13months, median 3 months.
Results: Average data integrity 83.1% and no statistical
relationshipsbetweengender, age, durationof pain, numberdiscs
treated and patients’ percentage global perceived improvement
(%GI). Mean improvements in initial to final 100mm VAS score
in average daily back pain were 58.2, 29.3 (49.6%), worst back
pain: 74.7, 39.9 (46.6%), average daily leg pain: 36.9, 13.8
(62.7%), worst leg pain: 41.2, 20.0, (51.5%), area of pain: 11.3,
5.2 (52.8%), Oswestry DI 40.1, 27.1 (32,5%). Mean patients’ GI
was 57.4%. overall, 22% failed and 68% achieved more than 50%
GI (mean 77.7%), 43.3% achieved over 75% (mean 87.7%). While
41 received Disc-FX with no other treatment, amongst 34 who
received prior treatment, only 3.9% of total numerical difference
in score was achieved before Disc -FX.
Conclusion: Percutaneous Decompression and Annulus
Denervation by Disc -FX contributes most of the improvement
recorded in the management of chronic discogenic spinal pain
in daily practice.
Speaker Biography
Anthony Hammond graduated from Edinburgh Medical School and trained as a general
physician and Rheumatologist in Bristol, Bath and London. He was a consultant at
Maidstone and Tunbridge Wells, NHS Trust till 2011 and now practices at The Kent
Institute, Maidstone, in London and Internationally. He is a SIS instructor and in
addition to a broad-based spinal pain practice has developed a special interest in the
minimally invasive and endoscopic treatment of disc related pain problems. He has
recently founded Insight Spine UK to develop this speciality.
e:
Anthony Hammond
KIMS Hospital, UK
Contribution of Discal Treatment by Disc-FXTM in a pathway of interventional management of
Back Pain and Sciatica in daily clinical practice